Consistent with the observed cancer cell growth inhibition, both XMU-MP-1 and YAP5SA inhibited HIF-2α pathway activity that is required for ccRCC cell growth in 3D cultures or mice. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.